Nanocarriers for Stroke Therapy: Advances and Obstacles in Translating Animal Studies
Syed Abdullah Alkaff, 1 Krishna Radhakrishnan, 1 Anu Maashaa Nedumaran, 1 Ping Liao, 2 Bertrand Czarny 1, 3 1School of Materials Science and Engineering, Nanyang Technological University 639798, Singapore; 2Calcium Signalling Laboratory, National Neuroscience Institute 308433, Singapore; 3Lee Kon...
Enregistré dans:
Auteurs principaux: | Alkaff SA, Radhakrishnan K, Nedumaran AM, Liao P, Czarny B |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/09845ea5166c44c680f130b5e37f95f1 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Thrombolytic Agents: Nanocarriers in Targeted Release
par: Minghua Shen, et autres
Publié: (2021) -
Extracellular Vesicles – Advanced Nanocarriers in Cancer Therapy: Progress and Achievements
par: Huyan T, et autres
Publié: (2020) -
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
par: Din FU, et autres
Publié: (2017) -
Physicochemical characterization of drug nanocarriers
par: Manaia EB, et autres
Publié: (2017) -
Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: an in vitro study
par: Cova E, et autres
Publié: (2019)